Skip to main content
. 2010 Feb 1;36(2):301–306. doi: 10.3892/ijo_00000500

Figure 5.

Figure 5

Gly and Myo levels distinguish control from brain tumor biopsies. Note that the major metabolite in GBM tumors was Gly whereas MT tumors contained substantial amounts of Myo. These data provide a clinically important distinction between MT and GBM.